公司资料
Guardant Health 股价、新闻与催化剂
- 股票代码:
- GH
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
161.67 USD (+2.84%)
收盘价
最后更新: 2026年8月17日
17.3B USD
市值
股价为何变动
As of Aug 17, 2026, GH closed up 2.84% at $161.67. No new same-company headline was identified in the current news window.
公司概览
业务概览
Guardant Health is a liquid-biopsy company focused on oncology diagnostics for screening, therapy selection, and disease monitoring.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Guardant sits in precision diagnostics.
商业模式特征
The business depends on test adoption, reimbursement, clinical utility, and the expansion of liquid biopsy into more use cases.
生物医药行业定位
Guardant is a leading oncology-diagnostics platform whose stock moves on adoption, reimbursement, and product performance.
未来催化剂
- Guardant Health's catalysts are Shield screening adoption, Reveal MRD traction, and any reimbursement or launch step that widens the oncology-diagnostics franchise. The company improves when screening and monitoring become more routine in clinical workflows.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。